Court cites serious allegations and public safety concerns in rejecting bail for alleged sale of toxic syrup linked to children's deaths.
In a significant ruling, the Madhya Pradesh High Court has dismissed the bail application of Smt. Jyoti Soni, who is embroiled in a high-profile case involving the sale of adulterated cough syrup. The judgment was delivered by Justice Pramod Kumar Agrawal at the Jabalpur bench, focusing on the grave allegations and the potential threat to public safety posed by the accused's actions.
Smt. Jyoti Soni, the proprietor of M/s Apna Medical Store, was implicated in the distribution of "Coldriff Syrup," which allegedly contained the toxic substance Diethylene Glycol (DEG). This adulterated syrup is reportedly linked to the deaths of over 26 children, causing widespread public health concerns. The prosecution argued that Soni, alongside co-accused individuals, substituted the prescribed "Nextro-PL" syrup with "Coldriff Syrup," which was not only unauthorized but also dangerous, resulting in fatal kidney reactions in children.
The court noted that Soni actively participated in the destruction of evidence and profited from the illegal sale, which further aggravated the charges against her. Despite her defense claiming innocence and lack of involvement in the manufacturing or adulteration of the syrup, the court found the allegations substantial enough to deny bail. The court emphasized the severity of the situation, highlighting the need to uphold public confidence and ensure safety.
The case has drawn significant attention due to the involvement of Soni's husband, Dr. Praveen Soni, a child specialist, who allegedly prescribed the toxic syrup. The prosecution underscored the coordinated efforts between the accused to gain financial benefits at the expense of public health, with both receiving commissions from the syrup's sales.
The judgment also pointed out the lack of traceability for the sold bottles and the deliberate concealment of statutory records, underlining the accused's breach of regulations under the Drugs and Cosmetics Act, 1940. The court's decision reflects a stringent stance on crimes impacting public health and safety, especially involving vulnerable populations like children.
This case references prior Supreme Court judgments, including Manoj Kumar Khokhar v. State of Rajasthan and Rohit Bishnoi v. The State of Rajasthan, reinforcing the legal principles applicable in cases with severe societal implications.
The ruling serves as a reminder of the judiciary's role in maintaining public trust and the importance of adhering to legal standards in pharmaceutical practices. The trial will proceed with the court's observations serving as a guideline for ensuring justice and accountability.
Bottom Line:
Bail application under Section 483 of Bharatiya Nagarik Suraksha Sanhita, 2023 dismissed for the alleged sale of adulterated cough syrup causing death of children and large-scale public health harm. The applicant's role in substituting prescribed medicine, destroying evidence, and profiting from the illegal sale was found to be serious enough to deny bail.
Statutory provision(s): Section 483 of Bharatiya Nagarik Suraksha Sanhita, 2023; Sections 105, 276, 238(B) of Bharatiya Nagarik Suraksha Sanhita; Section 27(A) of Drugs and Cosmetics Act, 1940; Drugs Rules, 1945.
Smt. Jyoti Soni v. State Of Madhya Pradesh, (Madhya Pradesh)(Jabalpur) : Law Finder Doc id # 2855093
